Torrent Pharmaceuticals has expanded its voluntary recall of its losartan potassium tablets to include five additional lots due to unacceptable amounts of N-Nitroso-N-methyl-4-aminobutyric acid, or NMBA, according to an FDA press release. The expanded ...
from Google Alert - health https://ift.tt/2QoqgHZ
via IFTTT
0 comments:
Post a Comment